Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 4, 2008, Pages 365-371

  Nakamura, Takamitsu ^a   Obata, Jun Ei ^a   Kitta, Yoshinobu ^a   Takano, Hajime ^a   Kobayashi, Tsuyoshi ^a   Fujioka, Daisuke ^a   Saito, Yukio ^a   Kodama, Yasushi ^a   Kawabata, Kenichi ^a   Mende, Akira ^a   Yano, Toshiaki ^a   Hirano, Mitsumasa ^a   Sano, Keita ^a   Nakamura, Kazuto ^a   Kugiyama, Kiyotaka ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Acute coronary syndromes; Carotid plaque; Plaque stabilization; Statin; Ultrasonic diagnosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; INSULIN; NITRIC ACID DERIVATIVE; PITAVASTATIN; TICLOPIDINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; ADVENTITIA; AGED; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; C-REACTIVE PROTEIN; CAROTID STENOSIS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUINOLINES; TIME FACTORS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42449116679     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318165dcad     Document Type: Article

References (31)

1. Ray KK, Cannon CP, McCabe CH, et al. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005;46:1405-1410.
2. Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol. 2005;46:1425-1433.
3. Crisby M, Nordin-Frerriksson G, Shah PK, et al. Pravastatin treatment increase collagen content and decrease lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implication for plaque stabilization. Circulation. 2001;103:926-933.
4. Bustos C, Hernandez-Presa MA, Ortego M, et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol. 1998;32:2057-2064.
5. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343:915-922.
6. Rothwell PM, Villarga R, Gibson R, et al. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet. 2000;355:19-24.
7. Grønholdt ML, Nordestgaard BG, Schroeder TV, et al. Ultrasonic echolucent carotid plaques predict future strokes. Circulation. 2001;104:68-73.
8. Polak JF, Shemanski L, O'Leary DH, et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adult aged 65 years or older. The Cardiovascular Health Study. Radiology. 1998;208:649-654.
9. Grønholdt ML, Nordestgaard BG, Bentzon J, et al. Machrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels. J Vasc Surg. 2002;35:137-145.
10. Takiuchi S, Rakugi H, Honda K, et al. Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries. Circulation. 2000;102:766-770.
11. Shepard RK, Miller JG, Wickline SA. Quantification of atherosclerotic plaque composition in cholesterol-fed rabbits with 50-MHz acoustic microscopy. Arterioscler Thromb. 1992;12:1227-1234.
12. Honda O, Sugiyama S, Kugiyama K, et al. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol. 2004;43:1176-1184.
13. Watanabe K, Sugiyama S, Kugiyama K, et al. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease. J Am Coll Cardiol. 2005;46:2022-2030.
14. Celletti F, Waugh J, Amabile P, et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med. 2001;7:425-429.
15. Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation. 1998;98:2108-2116.
16. Heliopoulos I, Papazoglou D, Piperidou H, et al. Carotid plaque echomorphology and serum vascular endothelial growth factor levels. Eur Neurol. 2004;51:104-108.
17. Papalambros E, Georgopoulos S, Sigala F, et al. Changes in circulating levels of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 after carotid endarterectomy. Int J Mol Med. 2004;14:133-136.
18. Alber HF, Dulak J, Frick M, et al. Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease. J Am Coll Cardiol. 2002;39:1951-1955.
19. Kodama Y, Kitta Y, Nakamura T, et al. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction. J Am Coll Cardiol. 2006;48:43-50.
20. Suzuki H, Tamaki T, Sato F, et al. Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs. Atherosclerosis. 1999;146:259-270.
21. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 1998;279:1643-1650.
22. Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet. 1996;348:1079-1082.
23. Nissen SE, Gurley JC, Grines CL, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation. 1991;84:1087-1099.
24. Kern MJ, Meier B. Evaluation of culprit plaque and physiological significance of coronary atherosclerotic narrowings. Circulation. 2001;103:3142-3149.
25. Schminke U, Hilker L, Motsch L, et al. Volumetric assessment of plaque progression with 3-dimensional ultrasonography under statin therapy. J Neuroimaging. 2002;12:245-251.
26. Tegos TJ, Kalomiris KJ, Sabetai MM, et al. Significance of sonographic tissue and surface characteristics of carotid plaques. Am J Neuroradiol. 2001;22:1605-1612.
27. Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999;99:1726-1732.
28. Heeschen C, Dimmeler S, Hamm C, et al. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndrome. Circulation. 2003;107:524-530.
29. Lee S, Wolf P, Escudero R, et al. Early expression of angiogenesis factors in acute myocardial infarction. N Engl J Med. 2000;342:626-633.
30. Monroe VS, Kerensky RA, Rivera E, et al. Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndrome. J Am Coll Cardiol. 2003;41:23S-30S.
31. Ambrose JA, Martinez EE. A new paradigm for plaque stabilization. Circulation. 2002;105:2000-2004.